As the holidays approach each year, I’m asked the same tender question: How do I honour my loved one when the season feels so full of their absence? It’s such a deeply human question. The holidays ...
Globally, more than 1 billion people currently live with obesity. The World Health Organization on Monday released new guidance on GLP-1 medications for adults with obesity, recommending their ...
Having a baby isn't all cuddles and coos. The postpartum period is marked by sleepless nights, upturned schedules, hormone shifts – and sometimes severe depression and anxiety. Adding to all that is ...
Telehealth companies are promoting GLP-1 medications such as Ozempic and Wegovy for cosmetic weight loss in non-obese patients, despite FDA limitations on their approved use, according to a Nov. 24 ...
Did you hear about Serena Williams? She just came out!” I had arranged to speak with a woman I’ll call Katherine, 37, a wardrobe stylist in St. Louis, who takes Zepbound to help manage symptoms of ...
In the fight against cancer, an important field of research is the search for safe alternatives to chemotherapy and radiotherapy. These treatments attack both cancer cells and healthy cells, exposing ...
A bipartisan bill introduced in the U.S. Senate Oct. 28 seeks to forbid companies from providing minors with access to artificial intelligence chatbot companions such as Character.ai and Replika. The ...
The obesity rate in the U.S. is continuing its downward trend. The news comes three years after obesity rates hit a record high. In 2022, almost four out of 10 (39.9%) of Americans met the threshold ...
Smart Split automatically turns videos longer than a minute into bite-size clips reframed vertically for phones. Smart Split automatically turns videos longer than a minute into bite-size clips ...
Please provide your email address to receive an email when new articles are posted on . There are limited numbers of FDA-approved medications to treat alcohol and substance use disorders. Preclinical ...
Moderna threw in the towel on an mRNA vaccine for congenital cytomegalovirus after it failed to prevent infection in a phase III trial of seronegative women of childbearing age. Twenty-five states ...